American Initiative in Mast Cell D… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2021

Legal Domicile

Phone

6503879791

Tax Period

2024-01-01 to 2024-12-31

American Initiative in Mast Cell Diseases, founded in 2021, is a small nonprofit in the Health Care sector that reported $295K in total revenue in fiscal year 2024.

Mission

To advance the research, education, and treatment of mastocytosis and related mast cell diseases.

Program Service Accomplishments

Program 1

Expenses: $276,092

Creating a network consisting of Centers of Excellence and Reference Centers in the United States, Canada, Central, and South America to advance the research, education, and treatment of mastocytosis...

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $294,725

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $294,725

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $276,092

Other Expenses $288,711

TOTAL EXPENSES $288,711

Year-over-Year Comparison

	2024	2023	Change
Revenue	$294,725	N/A	N/A
Expenses	$288,711	N/A	N/A
Net Income	$6,014	N/A	N/A

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Melody Carter	Director	0.00	Director	$0	$0	$0
Mariana Castells	Director	0.00	Director	$0	$0	$0
Jason Gotlib	President	0.00	Officer	$0	$0	$0
Cem Akin	Vice President	0.00	Officer	$0	$0	$0
Tracy George	Secretary	1.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$294,725	$288,711	$33,357	$6,014

American Initiative in Mast Cell Diseases